We are live on ! Find out more
VRNA

Verona Pharma

Delisted

VRNA was delisted on the 6th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$21.4M
RCM
2
RA Capital Management
Massachusetts
$21.4M
Wellington Management Group
3
Wellington Management Group
Massachusetts
$16M +$211K +49,364 +1%
PA
4
Perceptive Advisors
New York
$12.2M -$552K -129,157 -4%
VC
5
Vivo Capital
California
$11.5M
A
6
Abingworth
United Kingdom
$10.2M +$4 +1 +0%
ACM
7
Aisling Capital Management
New York
$5.58M
FCMI
8
Foresite Capital Management III
California
$4.66M
SB
9
Samsara BioCapital
California
$4.66M
FFM
10
Fairmount Funds Management
Pennsylvania
$3.88M
NHAS
11
Novo Holdings A/S
Denmark
$3.19M
TCM
12
Tekla Capital Management
Massachusetts
$3.15M
WP
13
Woodline Partners
California
$2.1M +$2.14M +501,458 New
VP
14
venBio Partners
California
$678K
SSA
15
Schonfeld Strategic Advisors
New York
$227K -$17.5K -4,100 -7%
IC
16
Ikarian Capital
Texas
$200K +$1.28M +300,000 New
DADC
17
D.A. Davidson & Co
Montana
$186K -$15K -3,500 -7%
BFM
18
Boothbay Fund Management
New York
$160K +$164K +38,280 New
Renaissance Technologies
19
Renaissance Technologies
New York
$118K +$121K +28,200 New
FA
20
Forefront Analytics
Pennsylvania
$112K -$36.2K -8,460 -24%
HSBC Holdings
21
HSBC Holdings
United Kingdom
$69K
Geode Capital Management
22
Geode Capital Management
Massachusetts
$60K
IIA
23
IPG Investment Advisors
California
$50K
Goldman Sachs
24
Goldman Sachs
New York
$49K +$49.6K +11,593 New
Citadel Advisors
25
Citadel Advisors
Florida
$45K +$46K +10,749 New